Overview: Total Estrogen TestIntroduction: The Total Estrogen Test measures total estrogen levels to assess hormonal imbalances, causing infertility or menopausal symptoms. Following 2023 Endocrine Society guidelines, it uses an immunoassay for high sensitivity, aiding in endocrine screening. This test is critical for guiding diagnosis, treatment, and improving outcomes in endocrinology for patients with suspected hormonal disorders.
Other Names: Estrogen Total Assay, Combined Estrogen Test.
FDA Status: Laboratory-developed test (LDT), meeting endocrinology standards for diagnostic accuracy.
Historical Milestone: Estrogen testing began in the 1970s with hormone research. Total estrogen immunoassays emerged in the 1990s, and by the 2000s, high-sensitivity assays improved accuracy.
Purpose: Diagnoses hormonal imbalances, guides treatment, and monitors total estrogen levels in patients with infertility or menopausal symptoms.
Test Parameters: 1. Total Estrogen
Pretest Condition: Fasting for 10-12 hours required to stabilize hormone levels. Collect serum, plasma, or urine in the morning. Report symptoms like infertility or menopausal symptoms, and list medications.
Specimen: 2-5 mL serum (SST), 2-4 mL plasma (EDTA), or 50-100 mL urine (24-hour collection, sterile container). Centrifuge serum/plasma within 1 hour. Transport in a biohazard bag within 8 hours.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document infertility, menopausal symptoms, or history of hormonal disorders. Include current medications, especially hormonal therapies.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for hormonal therapy.
Procedural Considerations: Uses an immunoassay to measure total estrogen levels. Results are available in 3-5 days, enabling clinical decisions.
Factors Affecting Result Accuracy: Non-fasting, stress, or medications can affect results. Hemolysis may degrade samples.
Clinical Significance: Abnormal total estrogen levels suggest hormonal imbalances, prompting treatment. Normal levels may require further testing.
Specialist Consultation: Consult an endocrinologist or reproductive specialist for result interpretation.
Additional Supporting Tests: Estradiol, FSH, or pelvic ultrasound to confirm hormonal disorders.
Test Limitations: Results may be affected by medications or stress. Clinical correlation is required.
References: Endocrine Society Hormone Guidelines, 2023; Journal of Clinical Endocrinology, Stanczyk FZ, 2022.
